EMCDDA 25 Years of Monitoring
In 2020, the EMCDDA celebrates 25 years of monitoring the drug situation in Europe.
Search
ASAP-Training Newsletter
The aim of the ASAP training project is to build effective drug prevention results across Europe, based on prevention systems analysis and widespread professional training.
The ASAP training project will work to identify the strengths and...
Monitoring the Elimination of Viral Hepatitis as a Public Health Threat in Europe
This technical report focuses on an elimination barometer for viral hepatitis to help countries assess progress towards eliminating hepatitis C and B among people who inject drugs (PWID).
The barometer is being developed by the EMCDDA...
Prevention of Drug-Related Deaths
Opioids are a class of drugs that act on the nervous system to produce feelings of pleasure and pain relief. Opioids have a high potential for causing addiction in some people and can cause life-threatening health problems, including the...
EDPQS Toolkit 4: Adaptation and Dissemination
The European Drug Prevention Quality Standards have been 
established to provide a comprehensive set of criteria to help users learn how to recognise 'high quality' prevention activities, outline the necessary structurally and procedural...
EDPQS Toolkit 3: Training
The European Drug Prevention Quality Standards have been 
established to provide a comprehensive set of criteria to help users learn how to recognise 'high quality' prevention activities, outline the necessary structurally and procedural...
EDPQS Toolkit 2: Self-Assessment & Reflection
The European Drug Prevention Quality Standards have been 
established to provide a comprehensive set of criteria to help users learn how to recognise 'high quality' prevention activities, outline the necessary structurally and procedural...
EDPQS Toolkit 1: Funding & Decision-Making
The European Drug Prevention Quality Standards have been established to provide a 
comprehensive set of criteria to help users learn how to recognise 'high quality' prevention activities, outline the necessary structurally and procedural...
Hepatitis C New Models of Care for Drugs Services
Hepatitis C virus (HCV) infection has a high prevalence in people who inject drugs in Europe, although HCV infection is both preventable and curable.
European clinical guidelines recommend that all patients with chronic liver disease as a...
Xchange Prevention Registry
Xchange is an online registry of evidence-based prevention programmes. In its first phase, the registry will make available manualised interventions that European evaluation studies show have beneficial outcomes relating to substance use...
m-Health Applications for Responding to Drug Use and Associated Harms
Digital healthcare, also known as e-health, refers to tools and services that use information and communication technology to improve the prevention, diagnosis, treatment, monitoring and management of health.
Mobile health, or m-health...
Medical Use of Cannabis and Cannabinoids
The European Monitoring Centre for Drugs and Drug Addiction have released their first report on the medical use of cannabis.
The report is part of a new series called Cannabis, Controversies and Challenges, and is designed to explore the...
Models of Addiction
The science of addiction is complicated, and it continues to be a field where the debate over definitions, models, theories, and the most appropriate ways to respond continues.
EMCDDA's Insight Review provides a critical analysis of the...
Preventing Overdose Deaths in Europe
There were over 9000 fatal overdoses in Europe in 2016. Tackling this concerning issues remains a key priority for public health policy.
The European Monitoring Centre for Drugs and Drugs Addiction has published their latest perspective...
European Drug Report 2018
The European Monitoring Centre on Drugs and Drug Addiction (EMCDDA) has released their latest European Drugs report.
Covering 30 European countries the report explores drug trends, developments in prevention and treatment, public health...
United Kingdom Drug Situation: Focal Point Annual Report
The United Kingdom Focal Point on Drugs (UK Focal Point) 2017 report is available on the UK government's digital portal.
Based at Public Health England, the UK Focal Point is the national partner of the European Monitoring Centre for Drugs...
European Drug Report 2017
The European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) has recently released its European Drug Report for 2017. The document offers an overview of the drug situation across the continent. It covers drug supply and use as well...
High-Risk Drug Use and New Psychoactive Substances
‘High-risk drug use and new psychoactive substances’, a new report from the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA), takes a look at the emergence of more problematic forms of new psychoactive substance use among a...
What Is There to Know About Psychosocial Interventions in Drug Treatment?
Psychosocial interventions are psychological or social interventions used to tackle issues related to substance abuse and behavioural addictions. They can be employed to identify and treat problems, as well as to assist with user...
EMCDDA Treatment Standards and Best Practice
Discover what works (and what doesn't work) in the areas of drug prevention, treatment and social reintegration.
